Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
05/2004
05/13/2004US20040092770 Alpha-haloenamine reagents
05/13/2004US20040092598 Antiproliferative agnets; anticancer agents; skin disorders
05/13/2004US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
05/13/2004US20040092559 Bicyclic modulators of androgen receptor function
05/13/2004US20040092556 Aids therapy
05/13/2004US20040092521 Antihistamines; central nervous system disorders
05/13/2004US20040092517 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
05/13/2004US20040092495 Hypoglycemic agents; antidiabetic agents
05/13/2004US20040092453 Synergistic antineoplastic effect; side effect reduction
05/13/2004US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme
05/13/2004CA2501314A1 Methods for preparing n-arylated oxazolidinones via a copper catalyzed cross coupling reaction
05/12/2004EP1418171A1 Perfluoroalkylanilins
05/12/2004EP1417975A1 REMEDIES FOR DISEASES WITH BONE MASS LOSS HAVING EP sb 4 /sb AGONIST AS THE ACTIVE INGREDIENT
05/12/2004EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor
05/12/2004EP1417176A1 Substituted anthranilamides for controlling invertebrate pests
05/12/2004EP1416928A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
05/12/2004EP1341785A4 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
05/12/2004EP1163208B1 Caspase inhibitors and uses thereof
05/12/2004EP1102745B1 A process for the preparation of zofenopril calcium salt
05/12/2004EP1102592B1 Coumarin and related aromatic-based polymeric prodrugs
05/12/2004EP1097128B1 Imidamide derivatives
05/12/2004EP1052984B1 Antibacterial agents
05/12/2004EP0946510B1 Novel compounds with analgesic effect
05/12/2004CN1496353A Method for preparing amlodipine
05/12/2004CN1496347A Biguanide derivatives
05/12/2004CN1495188A Substituted tetrels metal complex, catalyst and olefin polymerization method
05/12/2004CN1495166A Organic acid salt of amlodipine
05/12/2004CN1495163A Novol pyrrole sulphamide compound
05/12/2004CN1495162A Preparation of thiol carbamate and thiocyanic ester compound
05/12/2004CN1495161A Dithiocarbamate
05/12/2004CN1494906A Application of compound in preparation of medicine for preventing and curing multiple drug resistance
05/12/2004CN1149192C Process for preparing protected 4-aminomethyl-pyrrolidin-3-one
05/12/2004CN1149081C Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia
05/11/2004US6734318 Fluorous triphase and ther multiphase systems for effecting reactions and/or separation
05/11/2004US6734311 Substituted amidine derivatives as inhibitors of cell adhesion
05/11/2004US6734206 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure
05/11/2004US6734201 8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
05/11/2004US6734186 Phosphodiesterase 2 inhibitor
05/11/2004US6734182 Aryl sulfonamides and sulfamide derivatives and uses thereof
05/11/2004US6734181 Gastric acid secretory inhibition activity, gastric mucous membrane protection activity; treatment of ulcers and helicobacter pylori infecions
05/11/2004US6734154 Contacting the substrate with a mono-, di-, or trialkoxy-substituted perfluoroalkane, perfluorocycloalkane, or perfluorocycloalkyl(ene)- containing perfluoroalkane
05/11/2004US6733958 Material for photo-alignment layer, photo-alignment layer and method of manufacturing the same
05/11/2004US6733693 Acrylonitrile solutions of maleimides, method for preparation thereof, and acrylonitrile based copolymers obtained by use of the solutions
05/06/2004WO2004037818A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections
05/06/2004WO2004037813A1 Pyrrolidin-2-on derivatives as ep4 receptor agonists
05/06/2004WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands
05/06/2004WO2004037796A2 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
05/06/2004WO2004037787A1 1-phenylpyrrolidine-2-one-3-carboxamides
05/06/2004WO2004037784A2 Pyrrolidones with anti-hiv activity
05/06/2004WO2004037373A2 CHEMICAL CHAPERONES AND THEIR EFFECT UPON THE CELLULAR ACTIVITY OF β-GLUCOSIDASE
05/06/2004WO2004037257A1 Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators
05/06/2004WO2004037248A2 Modulation of peroxisome proliferator activated receptors activity
05/06/2004WO2004037171A2 Mitotic kinesin inhibitors
05/06/2004WO2004026822A3 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
05/06/2004WO2004011423A3 Structural carotenoid analogs for the inhibition and amelioration of disease
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004WO2002089800A3 N-aroyl cyclic amine derivatives as orexin receptor antagonists
05/06/2004US20040087790 Amidation of an alpha-keto formic acid with an alpha-carboxy alkylenimine; reducing the ketoamide formed to a hydroxyamide; and cyclizing
05/06/2004US20040087647 Enzyme inhibitors; prevent thrombosis; anticoagulants
05/06/2004US20040087646 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
05/06/2004US20040087632 Controlling metabolism of lipids, cholesterol
05/06/2004US20040087591 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use
05/06/2004US20040087585 Peptide deformylase inhibitors
05/06/2004US20040087583 Kinase inhibitors; antiinflammatory agents; autoimmune diseases; anticancer agents
05/06/2004US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents
05/06/2004US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists
05/06/2004US20040087573 Phenylpiperidines and phenylpyrrolidines
05/06/2004US20040087570 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
05/06/2004US20040087453 Photo-labile pro-fragrance conjugates
05/06/2004US20040086650 For use as solvents e.g., in cleaning procedures such as dry cleaning, water removal and in coating
05/06/2004EP1415995A2 Photocleavable agents and conjugates for the detection and isolation of biomolecules
05/06/2004EP1415987A1 Nitrogenous aromatic ring compounds
05/06/2004EP1414801A1 Arylamines for the treatment of conditions associated with gsk-3
05/06/2004EP1414796A1 Crystalline forms vi and vii of atorvastatin calcium
05/06/2004EP1414795A1 Bicyclic modulators of androgen receptor function
05/06/2004EP1414794A1 Allylmercaptocaptopril compounds and uses thereof
05/06/2004EP1414792A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates
05/06/2004EP1414440A1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
05/06/2004EP1414439A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
05/06/2004EP1414392A1 Primary intermediates for oxidative coloration of hair
05/06/2004EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
05/06/2004EP1163237B1 Amide derivatives
05/06/2004EP1088825B1 Enantiomerically pure substituted oxaaza compounds, salts of the same, and processes for the preparation of both
05/06/2004EP0968182B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/06/2004CA2504272A1 Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators
05/06/2004CA2503471A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections
05/06/2004CA2502478A1 1-phenylpyrrolidine-2-one-3-carboxamides
05/06/2004CA2500848A1 Mitotic kinesin inhibitors
05/05/2004CN1494528A Benzophenones as inhibitors of reverse transcriptase
05/05/2004CN1494425A Carboxamide derivatives as therapeutic agents
05/05/2004CN1148372C Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha 1-blocking action
05/05/2004CN1148350C Novel VLA-4 inhibitor: oMePUPA-V
05/05/2004CN1148349C N-substituted-N'-substituted urea derivative and use thereof as TNF-Alpha production inhibitor
05/05/2004CN1148346C Hydrazine derivs.
05/04/2004US6730798 Simultaneous halogenation and hydroxylation under lactonization, azidation, then amination to form 2(s),4(s),5(s),7(s)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides
05/04/2004US6730797 Process for producing crystalline atorvastatin calcium
05/04/2004US6730792 β3 adrenergic agonists
05/04/2004US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants
05/04/2004US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors
05/04/2004US6730678 Benzoylguanidine salt and hydrates thereof